PT Bio Farma
50
2
2
40
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.0%
1 terminated/withdrawn out of 50 trials
97.6%
+11.0% vs industry average
30%
15 trials in Phase 3/4
0%
0 of 40 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (50)
Study Interchangeability Hep-B Vaccine Administered at Birth Dose
Role: lead
Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh
Role: collaborator
Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in Children
Role: lead
A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations
Role: lead
Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama
Role: collaborator
Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
Role: collaborator
Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients
Role: lead
Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Role: lead
Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
Role: lead
Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
Role: lead
Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV
Role: lead
Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age
Role: lead
Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
Role: lead
Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian
Role: lead
Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children
Role: lead
Post Authorization Safety Profile of Booster IndoVac COVID-19 Vaccination
Role: lead
Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants
Role: lead
Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine
Role: lead
Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates
Role: lead
Post Authorization Safety Study Moderna COVID-19 Primary Vaccine
Role: lead